← Back to headlines
Eli Lilly Market Share Drops in India Amid Generic Weight-Loss Drug Surge
Eli Lilly is losing market share in India's GLP-1 market due to the influx of cheap semaglutide generics, while Novo Nordisk maintains its position through price cuts for Ozempic and Wegovy.
10 Apr, 06:38 — 10 Apr, 06:38
Related Stories
Philippines Health Secretary Herbosa calls expired medicine complaints a 'demolition job'
just now
PhilHealth eyes accreditation of pediatric neurologists for autism care
just now
Iloilo City Warns Against 'Tulingan' Fish Amid Food Poisoning Cases
just now
Iloilo experiences 'extreme caution' heat index levels, health warnings issued
just now